Publications by authors named "K Dalsgaard"

Claim this Profile
P
Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Asa Schiött, Kristina Larsson, Søren Manniche, Suzanne Kalliomäki, Annette Vinther Heydenreich, Kristian Dalsgaard

Int J Pharm· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
A M Mowat, A M Donachie, S Jägewall, K Schön, B Löwenadler, K Dalsgaard

J Immunol· September 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus.
J P Langeveld, F R Brennan, J L Martínez-Torrecuadrada, T D Jones, R S Boshuizen, K Dalsgaard

Vaccine· June 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge.
S Finerty, C R Stokes, T J Gruffydd-Jones, T J Hillman, N A Reeves, K Dalsgaard

Vaccine· August 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
K J Stittelaar, J Boes, G F Kersten, A Spiekstra, P G Mulder, K Dalsgaard

Vaccine· May 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis